Interaction Guide · Research summary

Can I take Piper Methysticum with Methadone?

Review Piper Methysticum with Methadone: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Kava may add to methadone-related drowsiness or impairment. Review co-use with the prescriber; an exact added risk or safe spacing interval has not been established.

What this answer covers

Piper methysticum preparations; beverages and extracts differ.

Supplement or preparation
Piper methysticum
Medication ingredient
methadone

The supplement can affect alertness

Supplement guidance cautions about other sedating substances. Lack of sleep or anxiety benefit in a kava/valerian trial does not prove absence of impairment.

Methadone adds a serious medication risk

Methadone has variable, prolonged effects and can impair breathing, especially with other CNS depressants. A general warning supports caution but does not provide this supplement pair’s event rate.

Product and treatment details matter

Dose, other medicines and the prescribed methadone formulation affect the assessment. The evidence does not establish a universal supplement dose limit or protective gap.

Keep changes coordinated with the prescriber

Tell the treatment team before adding or changing the supplement. Do not change methadone yourself. Avoid driving while impaired; slow breathing or unusual difficulty waking requires emergency help.

Evidence and practical considerations

Side effects & toxicity

Conditional additive-drowsiness precaution supported by exact methadone label and supplement-specific effects/guidance; current sedation claim not replaced by a different serotonin endpoint.

Exact scope
Piper methysticum preparations; beverages and extracts differ. with Methadone6813 IN; exact oral hydrochloride preparation and injection distinguished; maintenance-study limits retained.
Medication form and route
oral medication; parenteral medication; oral supplement

What remains uncertain

  • No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.

Factors that may matter: Preparation; Dose; Other medicines; Organ function.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed methadone

Long/variable elimination, respiratory depression, CNS-depressant and QT warnings; enzyme interactions including St John’s wort can change exposure.

How this applies: Exact methadone RxCUI 6813 IN, with stated salt/formulation/route bridge.

Not interchangeable administration with swallowed tablets, concentrates or injection; opioid-use-disorder care must remain supervised.

Source 2: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed methadone

CNS-depressant and metabolic interaction precautions; individual dose and response vary.

How this applies: Exact methadone RxCUI 6813 IN, with stated salt/formulation/route bridge.

Oral grapefruit studies do not establish an injected-drug intestinal interaction.

Source 3: federal supplement safety guidance

nccih.nih.gov · Source check Sep 10, 2026

Population: Users of the specified supplement.

Kava should not be used with other sedating substances. Various kava products have been linked to rare liver injury, sometimes serious or fatal.

How this applies: Original source interpreted for methadone only within the stated preparation and endpoint limits.

Not a direct methadone combination trial; original preparation, dose and endpoint limits apply. No exact-pair adverse-event rate or protective spacing established.

Source 4: original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 391 participants with anxiety and insomnia.

Neither botanical improved its primary anxiety/insomnia outcome over placebo.

How this applies: Original source interpreted for methadone only within the stated preparation and endpoint limits.

Not a direct methadone combination trial; original preparation, dose and endpoint limits apply. No exact-pair adverse-event rate or protective spacing established.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Prepared exact methadone article with formulation-specific evidence and uncertainty.
Research summary published

Article revision: 83c90a5246988046

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.